TrialPloS one2022

Early cerebral hypoxia in extremely preterm infants and neurodevelopmental impairment at 2 year of age: A post hoc analysis of the SafeBoosC II trial.

Anne Mette Plomgaard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.